(R)-N-(1,5-diphenylpentyl)-4-methylbenzenesulfonamide (5d)
Deliquescent white solid, yield: 21% (17 mg), purified on SiO2 (hexane/EtOAc gradient 8:1 to 3:1).
1
IR: 3272 (N-H), 2926 (C-H), 2856 (CH2), 1320 (S=O), 1154 (S=O) cm-1. H NMR (600 MHz, CDCl3): δ =
7.55 – 7.51 (m, 2H), 7.26 – 7.23 (m, 2H), 7.19 – 7-14 (m, 4H), 7.12 – 7.07 (m, 4H), 7.01 – 6.97 (m, 2H),
4.85 (d, J = 7.3 Hz, 1H, NH), 4.25 (q, J = 7.3 Hz, 1H), 2.51 – 2.47 (m, 2H), 2.35 (s, 3H), 1.79 (dddd, J =
12.8, 10.2, 7.1, 5.5 Hz, 1H), 1.74 – 1.66 (m, 1H), 1.55 – 1.49 (m, 2H), 1.33 – 1.26 (m, 1H), 1.20 – 1.11
(m, 1H) ppm. 13C NMR (151 MHz, CDCl3): δ = 142.9, 142.2, 140.9, 137.6, 129.3, 128.4, 128.3, 128.2,
127.3, 127.0, 126.4, 125.7, 58.2, 37.4, 35.6, 30.9, 25.5, 21.4 ppm. HRMS (HESI): m/z [M]- calcd for
C24H27NO2S: 392.1690, found: 392.1679. HPLC: Chiralpak IB, hexane/i-PrOH = 93:7, 1 mL/min, 222
nm, tR(major) = 11.25 min, tR(minor) = 18.47 min. [α]20589 +16.3 (c 0.35, CHCl3) for 43% ee.
(R)-N-(1-(4-chlorophenyl)-4-(p-tolyl)butyl)thiophene-2-sulfonamide (5e)
White solid, 42% yield, 32% ee, m.p. 84.2 – 85.5 °C, purified on SiO2 (hexane/EtOAc gradient 8:1 to
3:1). 1H NMR (600 MHz, CDCl3): δ= 7.45 (dd, J = 5.1, 1.3 Hz, 1H), 7.31 (dd, J = 3.7, 1.3 Hz, 1H), 7.17 –
7.13 (m, 2H), 7.06 (d, J = 7.7 Hz, 2H), 6.96 (t, J = 8.8 Hz, 4H), 6.89 (dd, J = 5.0, 3.8 Hz, 1H), 4.89 (d, J =
7.3 Hz, 1H), 4.35 (q, J = 7.3 Hz, 1H), 2.51 (t, J = 7.5 Hz, 2H), 2.30 (s, 3H), 1.82 – 1.73 (m, 1H), 1.72 –
1.65 (m, 1H), 1.61 – 1.56 (m, 1H), 1.48 – 1.40 (m, 1H). 13C NMR (151 MHz, CDCl3): δ= 141.6, 139.1,
138.3, 135.4, 133.3, 132.3, 131.8, 129.1, 128.7, 128.2, 127.8, 127.1, 57.9, 36.8, 34.7, 27.5, 20.9.
HRMS (HESI): m/z [M+H]+ calcd for C21H22ClNO2S2Na: 444.0643, found: 444.0648. HPLC: Chiralpak IB,
hexane/i-PrOH = 93:7, 1 mL/min, 222 nm, tR(major) = 16.8 min, tR(minor) = 21.3 min. [α]20589 +21.9 (c
0.2, CHCl3) for 32% ee.
(R)-N-(1-(4-trifluoromethyl)henyl)-4-(p-tolyl)butyl)-4-methylbenzenesulfonamide (5f)
White solid, yield: 21% (20 mg), m.p. 142.8-145.1°C, purified on SiO2 (hexane/EtOAc gradient 7:1 to
4:1). IR: 3259 (N-H), 2923 (C-H), 1319 (S=O), 1153 (S=O) cm-1. 1H NMR (600 MHz, CDCl3) δ 7.42 (d, J =
8.2 Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 7.05 (dd, J = 14.5, 7.6 Hz, 6H), 6.94 (d, J = 7.8 Hz, 2H), 4.72 (d, J =
7.0 Hz, 1H, NH), 4.37 (q, J = 7.1 Hz, 1H), 2.50 (t, J = 7.4 Hz, 2H), 2.32 (s, 3H), 2.30 (s, 3H), 1.76 (ddd, J =
12.8, 10.5, 6.1 Hz, 1H), 1.66 (ddd, J = 19.3, 11.7, 5.9 Hz, 1H), 1.62 – 1.55 (m, 1H), 1.50 – 1.39 (m, 1H)
ppm. 13C NMR (151 MHz, CDCl3): δ = 144.7, 143.3, 138.2, 127.3, 135.4, 129.2, 129.0, 128.2, 126.9,
126.9, 125.3, 125.2, 125.2, 125.2, 125.0, 57.7, 36.7, 34.6, 27.4, 21.3, 21.0 ppm. 19F NMR (564 MHz,
CDCl3) δ -62.7 (s) ppm. HRMS (HESI): m/z [M+H]+ calcd for C25H27F3NO2S: 462.1715, found: 462.1712.
HPLC: Chiralpak IB, hexane/i-PrOH = 90:10, 1 mL/min, 222 nm, tR(major) = 10.22 min, tR(minor) =
13.44 min. [α]20589 + 1.2 (c 0.25, CHCl3) for 26% ee.
Procedure for NMR experiments
For all NMR experiments an amberized, valved NMR tube was used (Norell S-5-600-VT-7). Before
setting up an experiment, the tube was connected to a Schlenk line, evacuated and backfilled with Ar
3 times. After addition of solid material, the procedure was repeated. The addition of solvent was
performed under constant Ar flow from the Schlenk line.
31P measurements: